🔎 Additional analyses from CheckMate 9DW presented at @ASCO #GI24 have shed further light on the clinical efficacy and safety of 1L #ipilimumab + #nivolumab for unresectable #hepatocellular carcinoma.

👉 Learn more about ipi/nivo's survival benefit: